FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Zoltan Rekasi

Research Profile

Chemicals & Drugs

Disorders

Prostatic Neoplasms

Anatomy

Procedures

Living Beings

Rats

Physiology

Gene Expression Regulation

Co-author Network

Publications

TOP 3
Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Marta Zarandi; Norman Block; Magdolna Kovacs; Mehrdad Nadji; Zoltan Rekasi
Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
Petra Popovics; Zoltan Rekasi; Alan J Stewart; Magdolna Kovacs
Regulation of pituitary inhibin/activin subunits and follistatin gene expression by GnRH in female rats.
Zoltan Rekasi; Reka A Horvath; Barbara Klausz; Eniko Nagy; Gabor L Toller
Suppression of serotonin N-acetyltransferase transcription and melatonin secretion from chicken pinealocytes transfected with Bmal1 antisense oligonucleotides containing locked nucleic acid in superfusion system.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Zoltan Rekasi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Marta Zarandi; Norman Block; Magdolna Kovacs; Mehrdad Nadji; Zoltan Rekasi
Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
The Journal of urology 2012;187(4):1498-504.
2011: Petra Popovics; Zoltan Rekasi; Alan J Stewart; Magdolna Kovacs
Regulation of pituitary inhibin/activin subunits and follistatin gene expression by GnRH in female rats.
The Journal of endocrinology 2011;210(1):71-9.
2006: Zoltan Rekasi; Reka A Horvath; Barbara Klausz; Eniko Nagy; Gabor L Toller
Suppression of serotonin N-acetyltransferase transcription and melatonin secretion from chicken pinealocytes transfected with Bmal1 antisense oligonucleotides containing locked nucleic acid in superfusion system.
Molecular and cellular endocrinology 2006;249(1-2):84-91.
2006: Gabor L Toller; Eniko Nagy; Reka A Horvath; Barbara Klausz; Zoltan Rekasi
Circadian expression of Bmal1 and serotonin-N-acetyltransferase mRNAs in chicken retina cells and pinealocytes in vivo and in vitro.
Journal of molecular neuroscience : MN 2006;28(2):143-50.
2005: Zoltan Rekasi; Tamas Czompoly; Andrew V Schally; Ferenc Boldizsar; Jozsef Varga; Marta Zarandi; Timea Berki; Reka A Horvath; Peter Nemeth
Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(9):3435-40.
2004: Jozsef Varga; Andrew V Schally; Judit E Horvath; Magdolna Kovacs; Gabor Halmos; Kate Groot; Gabor L Toller; Zoltan Rekasi; Marta Zarandi
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(6):1708-13.
2002: Gabor Halmos; Andrew V Schally; Tamas Czompoly; Magdalena Krupa; Jozsef Varga; Zoltan Rekasi
Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
The Journal of clinical endocrinology and metabolism 2002;87(10):4707-14.
2002: Zoltan Rekasi; Tamas Czompoly
Accumulation of rat pineal serotonin N-acetyltransferase mRNA induced by pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide in vitro.
Journal of molecular endocrinology 2002;28(1):19-31.
2002: Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Rebeca Busto; Zoltan Rekasi; Attila Nagy
Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.
Journal of neuroendocrinology 2002;14(1):5-13.
2001: Zoltan Rekasi; Andrew V Schally; Artur Plonowski; Tamas Czompoly; Balazs Csernus; Jozsef Varga
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
The Prostate 2001;48(3):188-99.
2001: Zoltan Rekasi; Jozsef Varga; Andrew V Schally; Artur Plonowski; Gabor Halmos; Balazs Csernus; Patricia Armatis; Kate Groot
Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways.
Peptides 2001;22(6):879-86.
2001: Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Zoltan Rekasi
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(4):1829-34.
2000: Andrew V Schally; Ana Maria Comaru-Schally; Artur Plonowski; Attila Nagy; Gabor Halmos; Zoltan Rekasi
Peptide analogs in the therapy of prostate cancer.
The Prostate 2000;45(2):158-66.
2000: Zoltan Rekasi; Tamas Czompoly; Andrew V Schally; Gabor Halmos
Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(19):10561-6.
2000: Gabor Halmos; Andrew V Schally; Jozsef Varga; Artur Plonowski; Zoltan Rekasi; Tamas Czompoly
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(19):10555-60.
2000: Artur Plonowski; Andrew V Schally; Jozsef Varga; Zoltan Rekasi; Francine Hebert; Gabor Halmos; Kate Groot
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
The Prostate 2000;44(2):172-80.
2000: Zoltan Rekasi; Jozsef Varga; Andrew V Schally; Gabor Halmos; Patricia Armatis; Kate Groot; Tamas Czompoly
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers.
Endocrinology 2000;141(6):2120-8.
2000: Zoltan Rekasi; Jozsef Varga; Andrew V Schally; Gabor Halmos; Kate Groot; Tamas Czompoly
Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(3):1218-23.